XNYSASIX
Market cap844mUSD
Jan 17, Last price
31.58USD
1D
2.33%
1Q
4.95%
Jan 2017
42.64%
IPO
64.48%
Name
AdvanSix Inc
Chart & Performance
Profile
AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,533,599 -21.18% | 1,945,640 15.49% | |||||||
Cost of revenue | 1,378,311 | 1,643,661 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 155,288 | 301,979 | |||||||
NOPBT Margin | 10.13% | 15.52% | |||||||
Operating Taxes | 14,600 | 53,905 | |||||||
Tax Rate | 9.40% | 17.85% | |||||||
NOPAT | 140,688 | 248,074 | |||||||
Net income | 54,623 -68.22% | 171,886 22.96% | |||||||
Dividends | (16,657) | (15,073) | |||||||
Dividend yield | 1.99% | 1.37% | |||||||
Proceeds from repurchase of equity | (45,275) | (32,444) | |||||||
BB yield | 5.40% | 2.94% | |||||||
Debt | |||||||||
Debt current | 32,053 | 37,472 | |||||||
Long-term debt | 329,975 | 307,614 | |||||||
Deferred revenue | 160,409 | ||||||||
Other long-term liabilities | 163,904 | (149,730) | |||||||
Net debt | 332,260 | 314,101 | |||||||
Cash flow | |||||||||
Cash from operating activities | 117,550 | 273,601 | |||||||
CAPEX | (107,377) | (89,449) | |||||||
Cash from investing activities | (110,897) | (189,273) | |||||||
Cash from financing activities | (7,870) | (68,443) | |||||||
FCF | 100,713 | 233,628 | |||||||
Balance | |||||||||
Cash | 29,768 | 30,985 | |||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | 601,249 | 563,640 | |||||||
Invested Capital | 1,169,155 | 978,872 | |||||||
ROIC | 13.10% | 26.34% | |||||||
ROCE | 13.28% | 26.51% | |||||||
EV | |||||||||
Common stock shares outstanding | 28,008 | 29,031 | |||||||
Price | 29.96 -21.20% | 38.02 -19.53% | |||||||
Market cap | 839,109 -23.98% | 1,103,763 -19.57% | |||||||
EV | 1,171,369 | 1,417,864 | |||||||
EBITDA | 228,298 | 371,332 | |||||||
EV/EBITDA | 5.13 | 3.82 | |||||||
Interest | 7,485 | 2,781 | |||||||
Interest/NOPBT | 4.82% | 0.92% |